How a postpartum depression pill could provide new hope for struggling mothers

Thousands of new moms suffer from postpartum depression without effective treatment. But a new postpartum depression drug approved in the U.S. — Zuranolone — could offer some hope. Two clinical trials found it effective and fast-acting. Guest host Anthony Germain speaks with a mom who participated in one of the trials and that trial’s principal investigator; and discusses the interest the drug is getting on our side of the border with Dr. Tuong Vi Nguyen, a reproductive psychiatrist at the McGill University Health Centre.